Email: info@triplemedicine.com
|
Admin: +201126600222 - +201003015145
|
Sales: +201034466858 - +201119743399
DIVISION OF SCIENTIFIC EXCELLENCE
Advancing Pharmaceutical Formulation & Scientific Innovation
At Triple Medicine, our dedicated Research & Development facility bridges cellular pharmacology and cosmeceutical precision. We engineer next-generation dermal therapeutics and high-efficacy stable medicine formulations under rigid clinical benchmarks.
CORPORATE CHARTER & STRATEGIC MISSION
Scientific Rigor with Public Responsibility
R&D PILLAR
Research & Development
« We are committed to applying the highest standards of quality and professional ethics across all our operations, while providing a safe and sustainable work environment that prioritizes employee health and safety. We also focus on building relationships based on trust and transparency with our partners and clients, supporting sustainable development and reinforcing our responsibility toward society. »
QUALITY PLEDGE
Corporate Responsibility
« We strive to establish an integrated pharmaceutical ecosystem that guarantees the safety of every medical and cosmetic product leaving our production lines. Building medical trust begins with raw material purity and extends to chemical analysis precision and periodic clinical testing. »
LOGISTICS & PARTNERSHIP
Distribution & Partnerships
« We seek to build successful strategic partnerships between suppliers and distributors based on trust and cooperation, ensuring sustainable relationships and achieving optimal outcomes for all stakeholders in the medical and cosmetic sectors. »
VISION & STRATEGY
Our Goal
« We aim to build an exceptional team capable of achieving company goals efficiently, delivering high-quality pharmaceutical products and services that fulfill customer needs, and strengthening our position as a trusted partner contributing to quality of life improvement. »
R&D Specialization
Core Pillars of Formulation Science
Bridging active pharmaceutical ingredients (APIs) and dermatological cosmeceuticals through validated stabilization science.
Dermal Delivery Systems
Micro-emulsions, nano-lipid carriers, and liposomal penetration enhancement tailored for cosmeceuticals and transdermal formulations.
Sustained Active Release
Deep Stratum Corneum Hydration
Dermal Delivery Systems
Micro-emulsions, nano-lipid carriers, and liposomal penetration enhancement tailored for cosmeceuticals and transdermal formulations.
Sustained Active Release
Deep Stratum Corneum Hydration
Microbiological Safety
Comprehensive challenge testing (PET) to guarantee preservative efficacy and sterility throughout the full product lifecycle.
28-Day Inoculation Studies
Bioburden Threshold Audits
Sustainable Formulation
Eco-conscious cold-process emulsification and biodegradable raw materials meeting global green chemistry regulations.
Low-Carbon Energy Protocols
Non-Toxic Effluent Processing
Quality Assurance Protocols
Rigorous Analytical Validation
Every therapeutic formulation developed at Triple Medicine undergoes multi-stage chromatographic assaying, accelerated thermal stress, and in-vitro diffusion monitoring before tech transfer.
Chromatographic Purity Analysis
Simultaneous quantitation of APIs and related substances under strict ICH Q2(R1) guidelines.
Active Assay & Stress Testing Matrix
Pharmacopoeial Validation Matrix (Batch Lot Release Protocol)
2024 Re-Validated
| Test Parameter | Analytical Methodology | ICH Standard | Tolerance Limit | Release Status |
|---|---|---|---|---|
| Active Potency (HPLC) | Reverse-Phase Isocratic UV-Vis | ICH Q1A(R2) | 98.5% – 101.5% | PASSED |
| Accelerated Stability | Climatic Chamber (40°C / 75% RH) | ICH Q1F | 6 Months Minimum | STABLE |
| Microbial Enumeration (TAMC) | Membrane Filtration Plate Count | USP <61> / EP 2.6.12 | < 100 CFU / g | STERILE |
| Heavy Metal Residues | Inductively Coupled Plasma (ICP-MS) | ICH Q3D | < 0.5 ppm Pb, Cd, As | PASSED |
| Transdermal Flux Rate | Franz Diffusion Cell Chamber | OECD 428 Guideline | Validated Rate Profile | OPTIMAL |
Dedicated R&D Formulators
0
+
Active Validated Master Formulas
0
+
Regulatory Compliance Rate
0
%
Sq. Meters Clinical Facility
0
K